{
    "nctId": "NCT05663723",
    "briefTitle": "Photobiomodulation for Prevention of Chemotherapy-induced Peripheral Neuropathy in Women With Breast Cancer",
    "officialTitle": "Photobiomodulation for Prevention of Chemotherapy-induced Peripheral Neuropathy in Women With Breast Cancer",
    "overallStatus": "NOT_YET_RECRUITING",
    "conditions": "Peripheral Nervous System Diseases AND Breast Neoplasms",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "PREVENTION",
    "enrollmentCount": 186,
    "primaryOutcomeMeasure": "Peripheral neuropathy",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Women aged over 18 years, with breast cancer in stages I to IIIC and who have an indication for curative treatment with neoadjuvant or adjuvant chemotherapy in HCIII/INCA.\n\nExclusion Criteria:\n\n* Patients with a previous diagnosis of another primary cancer\n* Patients undergoing surgery and/or chemotherapy at another Institution\n* Patients who previously had altered sensitivity in the feet\n* Patients who are unable to respond to questionnaires\n* Patients unable to receive photobiomodulation due to acute lower limb infections",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}